Key takeaways
DEA issued an order to show cause proposing to deny the registration of In-Dispensary, LLC, a Minneapolis medical cannabis applicant.
Its broadest reason: Minnesota's dual-purpose license, which covers both medical and adult-use sales, doesn't count as a "state medical marijuana license."
All 900+ first registrations went to Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia, none with operating adult-use markets.
The order isn't final. The applicant has 30 days to request a hearing and can propose a corrective action plan.
The DEA's first move on a dispensary in a state with both medical and adult-use cannabis is a proposed denial. For operators in dual-license states, that's the clearest signal yet that federal registration may not come on the same terms it did in medical-only markets.
The order to show cause went to In-Dispensary in Minneapolis and was signed by Cheri Oz, assistant administrator of DEA's Diversion Control Division, Marijuana Moment reported. It landed the same week the Justice Department announced its first 900-plus dispensary registrations on Oct. 30, 2026.
What the DEA order to show cause says
According to summaries from Foley Hoag and Marijuana Moment, DEA gave three separate grounds for denial, each tied to Minnesota's program:
The dual-purpose license. Minnesota lets one license holder sell to both patients and adult customers. DEA says that falls outside the federal definition of a state medical marijuana license and lacks protections against diversion.
Veteran self-attestation. Minnesota lets veterans join the medical program by attesting to a qualifying condition, without a practitioner's written certification.
Synthetic and hemp-derived products. Minnesota dispensaries can sell artificially derived cannabinoids, which DEA treats as synthetic and which remain in Schedule I.
Minnesota's Office of Cannabis Management told the Minnesota Star Tribune the order doesn't affect state law and that medical cannabis stays available to patients, according to Marijuana Moment and Business of Cannabis.
"To qualify, applicants must operate under a state medical marijuana regulatory framework consistent with federal law and the United States' international treaty obligations."
Why dual-license states are watching
The first round of registrations skipped every state with operating adult-use sales. Virginia is on the list, but it hasn't started adult-use licensing yet, Foley Hoag noted.
Meanwhile, most of the pending applications sit elsewhere. DEA's timely applicant list, in the file dated Nov. 5, 2026, has 6,074 entries across 42 states, Washington, D.C. and Puerto Rico. Our count of the largest state totals:
State | Entries on DEA's Nov. 5 list |
|---|---|
Oklahoma | 2,442 |
California | 771 |
Maine | 320 |
Pennsylvania | 227 |
Missouri | 209 |
Minnesota | 30 |
Foley Hoag cautions that the order doesn't guarantee denials elsewhere. Two of the three grounds are specific to Minnesota, and states separate medical and adult-use licenses, inventory and premises in different ways. But DEA hasn't said how much separation is enough.
How it fits with the Nov. 29 supply chain deadline
DEA's Oct. 30 guidance for timely applicants still applies: pending applicants may only trade with other timely applicants and registrants, and should have compliant supply chains by Nov. 29, 2026. The guidance says it does "not have the force and effect of law," but it shows how DEA will judge pending files.
For dual-use operators, Foley Hoag says this means a split supply chain. Registrations and the timely applicant safe harbor cover medical activity only, so adult-use activity gets no federal protection.
What this means for operators
Compare your state to Minnesota. Check whether your license is dual-purpose, how patients qualify, and whether you sell hemp-derived or synthetic cannabinoid products.
Document the separation. Be ready to show, through inventory tracking and records, that medical product moves only through medical channels.
Keep working toward Nov. 29. Vet every trading partner's status and keep records of it, whether or not your state is medical-only.
Prepare for an order to show cause. The Minnesota applicant got 30 days to respond, so have counsel and a possible corrective action plan lined up before you need them.
Review supply contracts. Foley Hoag suggests adding status representations and termination rights to supply agreements.
What this means for cannabis workers
Nothing changes on the shop floor in Minnesota today. State law still governs, and medical cannabis remains available, according to the state's cannabis office.
If you work for a dual-license operator, though, expect more paperwork around which products are medical and which are adult-use. Careful inventory and record handling is likely to matter more as DEA reviews these applications.
The bigger picture
This only covers the medical-marijuana carve-out. The broader proposal to move all marijuana to Schedule III is still in a separate DEA hearing before Chief Administrative Law Judge Derek Julius, Business of Cannabis reported.
Related on The Weekly Joint: DEA registers 900+ medical cannabis dispensaries · DEA felony rule puts medical cannabis jobs on the line · More rescheduling coverage
Sources
This article is general information, not legal or tax advice.
Get the week in cannabis business, every Tuesday
The Weekly Joint covers regulation, licensing, money and the cannabis workforce, with every story linked to its source. Free, once a week.
Prefer the scroll? Follow @weeklyjoint on Instagram.
